Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- QLGN
- Price
- 2.33
- Stock movement up
- +0.13 (5.39%)
- Company name
- Qualigen Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 5.16M
- Ent value
- 10.45M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -11.18%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -44.99%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2025-12-04
DIVIDENDS
QLGN does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 2.03M |
| EPS (TTM) | -3.23 |
| FCF per share (TTM) | -4.62 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.24M |
| Gross profit (TTM) | 1.10M |
| Operating income (TTM) | -5.42M |
| Net income (TTM) | -5.43M |
| EPS (TTM) | -3.23 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 49.20% |
| Operating margin (TTM) | -242.23% |
| Profit margin (TTM) | -242.92% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 38.78M |
| Net receivables | 4.35M |
| Total current assets | 43.47M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 43.47M |
| Accounts payable | 1.28M |
| Short/Current long term debt | 3.24M |
| Total current liabilities | 4.92M |
| Total liabilities | 4.92M |
| Shareholder's equity | 38.55M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -7.78M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -7.78M |
| Dividends paid (TTM) | 869.38K |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -14.10% |
| Return on Assets | -12.50% |
| Return on Invested Capital | -13.01% |
| Cash Return on Invested Capital | -18.62% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.45 |
| Daily high | 2.54 |
| Daily low | 2.33 |
| Daily Volume | 95K |
| All-time high | 597500.00 |
| 1y analyst estimate | 5.00 |
| Beta | 0.28 |
| EPS (TTM) | -3.23 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| QLGN | S&P500 | |
| Current price drop from All-time high | -100.00% | -2.53% |
| Highest price drop | -100.00% | -19.00% |
| Date of highest drop | 16 Sep 2025 | 8 Apr 2025 |
| Avg drop from high | -100.00% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 289 days | 89 days |
COMPANY DETAILS
Marketcap
5.16M
Marketcap category
Small-cap
Description
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was founded in 1996 and is based in Carlsbad, California.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner